Penumbra Inc’s filing revealed that its Director Grewal Harpreet acquired Company’s shares for reported $42330.0 on Nov 04 ’25. In the deal valued at $227.58 per share,186 shares were bought.
Then, Grewal Harpreet sold 186 shares, generating $46,241 in total proceeds. Upon selling the shares at $248.61, the Director now owns 8,702 shares.
Before that, Roberts Johanna sold 600 shares. Penumbra Inc shares valued at $149,820 were divested by the EVP, Gen. Counsel & Secretary at a price of $249.70 per share. As a result of the transaction, Roberts Johanna now holds 64,257 shares, worth roughly $15.11 million.
Needham upgraded its Penumbra Inc [PEN] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who began to cover the stock in early September with a ‘”an Outperform”‘ rating. BofA Securities began covering PEN with “Buy” recommendation on March 14, 2025. UBS started covering the stock on January 21, 2025. It rated PEN as “a Buy”.
Price Performance Review of PEN
On Tuesday, Penumbra Inc [NYSE:PEN] saw its stock jump 3.93% to $235.08. Over the last five days, the stock has lost -0.18%. Penumbra Inc shares have risen nearly 2.71% since the year began. Nevertheless, the stocks have fallen -1.01% over the past one year. While a 52-week high of $310.00 was reached on 02/19/25, a 52-week low of $221.26 was recorded on 11/03/25.
Levels Of Support And Resistance For PEN Stock
The 24-hour chart illustrates a support level at 229.77, which if violated will result in even more drops to 224.46. On the upside, there is a resistance level at 237.99. A further resistance level may holdings at 240.90.
How much short interest is there in Penumbra Inc?
A steep rise in short interest was recorded in Penumbra Inc stocks on 2025-10-15, dropping by -0.24 million shares to a total of 1.73 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 1.98 million shares. There was a decline of -14.12%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 17, 2024 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $275 price target.
